|
1
|
Yang W, Lu J, Weng J, et al: Prevalence of
diabetes among men and women in China. N Engl J Med. 362:1090–1101.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mbanya JC, Motala AA and Sobngwi E:
Diabetes in sub-Saharan Africa. Lancet. 375:2254–2266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jermendy G, Nadas J, Szigethy E, et al:
Prevalence rate of diabetes mellitus and impaired fasting glycemia
in Hungary: cross-sectional study on nationally representative
sample of people aged 20–69 years. Croat Med J. 51:151–156.
2010.PubMed/NCBI
|
|
4
|
Dieguez C, da Boit K, Novelle MG, et al:
New insights in ghrelin orexigenic effect. Front Horm Res.
38:196–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Vriese C, Perret J and Delporte C:
Focus on the short- and long-term effects of ghrelin on energy
homeostasis. Nutrition. 26:579–584. 2010.PubMed/NCBI
|
|
6
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Farooqi IS and O’Rahilly S: Leptin: a
pivotal regulator of human energy homeostasis. Am J Clin Nutr.
89:S980–S984. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coppari R, Ichinose M, Lee CE, et al: The
hypothalamic arcuate nucleus: a key site for mediating leptin’s
effects on glucose homeostasis and locomotor activity. Cell Metab.
1:63–72. 2005.
|
|
9
|
Cowley MA, Smith RG, Diano S, et al: The
distribution and mechanism of action of ghrelin in the CNS
demonstrates a novel hypothalamic circuit regulating energy
homeostasis. Neuron. 37:649–661. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Klok MD, Jakobsdottir S and Drent ML: The
role of leptin and ghrelin in the regulation of food intake and
body weight in humans: a review. Obes Rev. 8:21–34. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klok K, Sone H and Yada T: Ghrelin is a
physiological regulator of insulin release in pancreatic islets and
glucose homeostasis. Pharmacol Ther. 118:239–249. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reed MJ, Meszaros K, Entes LJ, et al: A
new rat model of type 2 diabetes: the fat-fed,
streptozotocin-treated rat. Metabolism. 49:1390–1394. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang F, Ye C, Li G, et al: The rat model
of type 2 diabetic mellitus and its glycometabolism characters. Exp
Anim. 52:401–407. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Srinivasan K, Viswanad B, Asrat L, Kaul CL
and Ramarao P: Combination of high-fat diet-fed and low-dose
streptozotocin-treated rat: a model for type 2 diabetes and
pharmacological screening. Pharmacol Res. 52:313–320. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Islam MS and Choi H: Nongenetic model of
type 2 diabetes: a comparative study. Pharmacology. 79:243–249.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peterson RG, Shaw WN and Neel MA: Zucker
diabetic fatty rat as a model for non-insulin-dependent diabetes
mellitus. ILAR News. 32:16–19. 1990. View Article : Google Scholar
|
|
17
|
Chang AY: Spontaneous diabetes in animals.
Gen Pharmacol. 9:447–450. 1978. View Article : Google Scholar
|
|
18
|
Woods SC, Seeley RJ, Rushing PA, D’Alessio
D and Tso P: A controlled high-fat diet induces an obese syndrome
in rats. J Nutr. 133:1081–1087. 2003.PubMed/NCBI
|
|
19
|
Ukkola O, Poykko S, Paivansalo M and
Kesäniemi YA: Interactions between ghrelin, leptin and IGF-I affect
metabolic syndrome and early atherosclerosis. Ann Med. 40:465–473.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pacifico L, Poggiogalle E, Costantino F,
et al: Acylated and nonacylated ghrelin levels and their
associations with insulin resistance in obese and normal weight
children with metabolic syndrome. Eur J Endocrinol. 161:861–870.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Serra-Prat M, Alfaro SR, Palomera E, et
al: Relationship between ghrelin and the metabolic syndrome in the
elderly: a longitudinal population-based study. Clin Endocrinol
(Oxf). 70:227–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Y, Asnicar M and Smith RG: Central and
peripheral roles of ghrelin on glucose homeostasis.
Neuroendocrinology. 86:215–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yada T, Dezaki K, Sone H, et al: Ghrelin
regulates insulin release and glycemia: physiological role and
therapeutic potential. Curr Diabetes Rev. 4:18–23. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dezaki K, Kakei M and Yada T: Ghrelin uses
Galphai2 and activates voltage-dependent K+ channels to
attenuate glucose-induced Ca2+ signaling and insulin
release in islet beta-cells: novel signal transduction of ghrelin.
Diabetes. 56:2319–2327. 2007.PubMed/NCBI
|
|
25
|
Wortley KE, del Rincon JP, Murray JD, et
al: Absence of ghrelin protects against early-onset obesity. J Clin
Invest. 115:3573–2578. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zigman JM, Nakano Y, Coppari R, et al:
Mice lacking ghrelin receptors resist the development of
diet-induced obesity. J Clin Invest. 115:3564–3572. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Flanagan DE, Evans ML, Monsod TP, et al:
The influence of insulin on circulating ghrelin. Am J Physiol
Endocrinol Metab. 284:E313–E316. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ueno M, Carvalheira JB, Oliveira RL,
Velloso LA and Saad MJ: Circulating ghrelin concentrations are
lowered by intracerebroventricular insulin. Diabetologia.
49:2449–2452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fick LJ, Cai F and Belsham DD:
Hypothalamic preproghrelin gene expression is repressed by insulin
via both PI3-K/Akt and ERK1/2 MAPK pathways in immortalized,
hypothalamic neurons. Neuroendocrinology. 89:267–275. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nogueiras R, Tovar S, Mitchell SE, et al:
Regulation of growth hormone secretagogue receptor gene expression
in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes.
53:2552–2558. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Al-Shoumer KA, Al-Asousi AA, Doi SA and
Vasanthy BA: Serum leptin and its relationship with metabolic
variables in Arabs with type 2 diabetes mellitus. Ann Saudi Med.
28:367–370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Levin BE, Dunn-Meynell AA, Ricci MR and
Cummings DE: Abnormalities of leptin and ghrelin regulation in
obesity-prone juvenile rats. Am J Physiol Endocrinol Metab.
285:E949–E957. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Myers MG, Cowley MA and Munzberg H:
Mechanisms of leptin action and leptin resistance. Annu Rev
Physiol. 70:537–556. 2008. View Article : Google Scholar : PubMed/NCBI
|
